Literature DB >> 10415599

Sex hormones and glucocorticoids: interactions with the immune system.

J A Da Silva1.   

Abstract

Gender and sex hormones exert powerful effects in the susceptibility and progression of numerous human and experimental autoimmune diseases. This has been attributed to direct immunological effects of sex hormones that impact a clear gender dimorphism on the immune system. Globally, estrogens depress T cell-dependent immune function and diseases, but enhance antibody production and aggravate B cell-dependent diseases. Androgens suppress both T-cell and B-cell immune responses and virtually always result in the suppression of disease expression. Defects in the hypothalamic-pituitary-adrenal (HPA) axis have been proposed to play an important role in the pathogenesis of autoimmune diseases. Glucocorticoid response to stress, including immune challenge, is strongly inhibited by androgens and enhanced by estrogens. Complex three-way interactions between these systems appear to be involved in gender dimorphism of the immune system. This paper reviews the mechanisms involved in interactions between sex steroids and the HPA axis, addresses the possibility of similar interactions on immunocompetent cells, and explores an integrated perspective of the impact of these interplays on the immune system.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10415599     DOI: 10.1111/j.1749-6632.1999.tb07628.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  59 in total

1.  Regulation of macrophage migration inhibitory factor expression by glucocorticoids in vivo.

Authors:  Gunter Fingerle-Rowson; Peter Koch; Rachel Bikoff; Xinchun Lin; Christine N Metz; Firdaus S Dhabhar; Andreas Meinhardt; Richard Bucala
Journal:  Am J Pathol       Date:  2003-01       Impact factor: 4.307

Review 2.  Sex-associated hormones and immunity to protozoan parasites.

Authors:  C W Roberts; W Walker; J Alexander
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

3.  The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain.

Authors:  R M Nissen; K R Yamamoto
Journal:  Genes Dev       Date:  2000-09-15       Impact factor: 11.361

Review 4.  Stress-induced sex differences: adaptations mediated by the glucocorticoid receptor.

Authors:  Chase H Bourke; Constance S Harrell; Gretchen N Neigh
Journal:  Horm Behav       Date:  2012-03-03       Impact factor: 3.587

Review 5.  Autoimmune mechanisms as the basis for human peripartum cardiomyopathy.

Authors:  Aftab A Ansari; James D Fett; Robert E Carraway; Ann E Mayne; Nattawat Onlamoon; J Bruce Sundstrom
Journal:  Clin Rev Allergy Immunol       Date:  2002-12       Impact factor: 8.667

6.  Disrupted glucocorticoid--Immune interactions during stress response in schizophrenia.

Authors:  Joshua Chiappelli; Qiaoyun Shi; Priyadurga Kodi; Anya Savransky; Peter Kochunov; Laura M Rowland; Katie L Nugent; L Elliot Hong
Journal:  Psychoneuroendocrinology       Date:  2015-09-12       Impact factor: 4.905

7.  Monocyte proinflammatory cytokine release is higher and glucocorticoid sensitivity is lower in middle aged men than in women independent of cardiovascular risk factors.

Authors:  P H Wirtz; R von Känel; N Rohleder; J E Fischer
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

8.  Production of native bispecific antibodies in rabbits.

Authors:  Wei Wang; Ruihuan Xu; Jinming Li
Journal:  PLoS One       Date:  2010-06-14       Impact factor: 3.240

9.  Genetic analysis of the influence of neuroantigen-complete Freund's adjuvant emulsion structures on the sexual dimorphism and susceptibility to experimental allergic encephalomyelitis.

Authors:  Parley D Fillmore; Matthew Brace; Scott A Troutman; Elizabeth P Blankenhorn; Sean Diehl; Mercedes Rincon; Cory Teuscher
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

10.  Sex differences in the inflammatory response to stress and risk of adverse cardiovascular outcomes among patients with coronary heart disease.

Authors:  Samaah Sullivan; An Young; Muhammad Hammadah; Bruno B Lima; Oleksiy Levantsevych; Yi-An Ko; Brad D Pearce; Amit J Shah; Jeong Hwan Kim; Kasra Moazzami; Emily G Driggers; Ammer Haffar; Laura Ward; Isaias Herring; Allison Hankus; Tené T Lewis; Puja K Mehta; J Douglas Bremner; Paolo Raggi; Arshed Quyyumi; Viola Vaccarino
Journal:  Brain Behav Immun       Date:  2020-09-08       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.